Drug Discovery Considerations of Therapeutic Antibodies explains the process through which biopharmaceutical companies, federal laboratories, and universities identify potential therapeutic entities using in silico, in vitro, and in vivo methodologies.
Suggested Prerequisites
Drug Discovery of Biologics
Takeaways
- Knowledge of the drug discovery workflow and how each specific goal is aligned for development.
- Understanding of the criteria used for early drug candidate selection and how the properties of therapeutic antibodies play into this selection.
- A deep understanding of in silico, in vitro, and in vivo models to explore functional pharmacology activity.
- Fluency in the four distinct classes of antibody therapeutics.
- Exploration of data and transition criteria that enable a candidate drug to move from the discovery phase into preclinical development.
